Minimally Invasive Decompression and Fusion Versus Open for Degenerative Lumbar Stenosis
An Open-Label Randomized Controlled Study of the Efficacy of Surgical Treatment in Patients With Single Level Lumbar Spinal Stenosis Using Minimally Invasive Decompression and Fusion and Traditional Open
1 other identifier
interventional
96
1 country
1
Brief Summary
The purpose of this study is to determine the effectiveness of minimally invasive decompression and fusion over the traditional open decompression and fusion in patients with single-level lumbar stenosis caused by degenerative spondylolisthesis. Postoperative follow-up will continue for 12 months. Сlinical, safety, radiological and cost-effectiveness endpoints will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2020
CompletedFirst Posted
Study publicly available on registry
October 20, 2020
CompletedStudy Start
First participant enrolled
January 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 3, 2026
March 1, 2026
2.1 years
October 10, 2020
March 1, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in Oswestry Disability Index (ODI)
To observe the change of ODI as compared to baseline through follow-up terms. min - 0, - the best result, patient is active; max - 50 - the worst result, patient is not physically active
3 months
Secondary Outcomes (16)
Change from baseline in Oswestry Disability Index (ODI)
Through 2 years
Change from baseline in Numeric Pain Rating Score (NPRS)
Through 2 years
Change from baseline in EuroQol Five-Dimensional descriptive system questionnaire (EQ-5D).
Through 2 years
Change from baseline in Douleur Neuropathique 4 (DN4)
Through 2 years
Change from baseline in The Health Transition Item from SF-36 (HTI Item)
Through 2 years
- +11 more secondary outcomes
Study Arms (2)
Minimally invasive TLIF
OTHERPatients will undergo a single level decompression and fusion using a minimally invasive technique. Followed posterior screw fixation is mandatory.
Open TLIF
OTHERPatients will undergo a single level decompression and fusion using an open traditional technique. Followed posterior screw fixation is mandatory.
Interventions
Transforaminal Lumbar Interbody Fusion will be performed using minimally invasive approach or traditional open technique.
Eligibility Criteria
You may qualify if:
- Age 40-75 years;
- Neurogenic claudication or bilateral radiculopathy caused by single level combination of degenerative stenosis and spondylolisthesis confirmed by MRI at one level L3-L4 or L4-L5 or L5-S1;
- Symptoms persisting for at least three months prior to surgery;
- Given written Informed Consent Form;
- Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
- Oswestry Disability Index score of at least 40/100 at baseline;
You may not qualify if:
- Bilateral foraminal stenosis requiring surgical decompression on both sides;
- Degenerative spondylolisthesis Type 2B, 3 subtypes by Gille;
- More than one symptomatic level requiring multi-level surgical decompression and/or fusion;
- Any condition that cannot be treated with mini-invasive unilateral decompression and fusion;
- Any contraindication or inability to undergo baseline and/or follow up MRI or X-ray as required per protocol;
- Spondylolisthesis grade II or higher of any etiology;
- Prior lumbar spinal fusion at any level;
- Other non-degenerative spinal conditions that may have an impact on subject safety, wellbeing or the intent and conduct of the study;
- History or presence of any other major neurological disease or condition that may interfere with the study assessments;
- Severe arterial insufficiency of the legs or other peripheral vascular disease;
- Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Priorov National Medical Research Center of Traumatology and Orthopedics
Moscow, 127299, Russia
Related Publications (1)
Leonova ON, Cherepanov EA, Krutko AV. MIS-TLIF versus O-TLIF for single-level degenerative stenosis: study protocol for randomised controlled trial. BMJ Open. 2021 Mar 5;11(3):e041134. doi: 10.1136/bmjopen-2020-041134.
PMID: 33674366DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2020
First Posted
October 20, 2020
Study Start
January 20, 2022
Primary Completion
February 27, 2024
Study Completion
March 1, 2026
Last Updated
March 3, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- During the study conducting and during 5 years after
- Access Criteria
- The approval of institutional review board will be necessary
Data are available upon reasonable request. Please contact the corresponding author for detail.